A REVIEW OF WHO MAKES WEIGHT LOSS DRUG COPYRIGHT

U.S. pharma big copyright scrapped two experimental weight loss drugs last year—a after-everyday pill, lotiglipron, on account of elevated liver enzymes and also a twice-day by day tablet, danuglipron, as a consequence of potent Uncomfortable side effects—but CEO Albert Bourla has claimed the company is determined to “Perform and win” withi